The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation.

Clin Transl Radiat Oncol · 2022 · PMC8881198 · PMID 35243023

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)

Patients with no relevant hypoxia (HSV <1 mL) at baseline (n = 6) showed a trend towards decreased osteopontin levels compared to patients with hypoxic tumors (55.3 vs. 84.5 ng/mL, p = 0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.